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Background and aims: Limited treatment options are available for trichotillomania (TTM) and most have modest
outcomes. Suboptimal treatment results may be due to the failure of existing approaches to address all TTM styles.
Methods: Thirty-eight DSM-IV TTM participants were randomly assigned across two study sites to Dialectical Be-
havior Therapy (DBT) -enhanced cognitive-behavioral treatment (consisting of an 11-week acute treatment and
3-month maintenance treatment) or a minimal attention control (MAC) condition. MAC participants had active treat-
ment after the 11-week control condition. Follow-up study assessments were conducted three and six months after
the maintenance period. Results: Open trial treatment resulted in significant improvement in TTM severity, emotion
regulation (ER) capacity, experiential avoidance, anxiety and depression with changes generally maintained over
time. In the randomized controlled trial, those with active treatment had greater improvement than those in the MAC
condition for both TTM severity and ER capacity. Correlations between changes in TTM severity and ER capacity
were not reported at post-treatment but did occur in maintenance and follow-up indicating reduced TTM severity
with improved ER capacity. Conclusions: DBT-enhanced cognitive-behavioral treatment is a promising treatment
for TTM. Future studies should compare this approach to other credible treatment interventions and investigate the
efficacy of this approach in more naturalistic samples with greater comorbidity.
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INTRODUCTION
Meta-analytic research (Bloch et al., 2007) and expert clini-
cian consensus (Flessner, Penzel, Trichotillomania Learning
Center Scientific Advisory Board & Keuthen, 2010) have
identified cognitive-behavioral treatment as the first-line
treatment intervention for trichotillomania (TTM). Despite
evidence for acute benefit for TTM with cognitive-behav-
ioral treatment, concerns regarding inadequate treatment re-
sponse and symptom relapse post-treatment continue to
overshadow the field.
Failure to achieve greater, and more enduring, symptom
reduction with traditional Habit Reversal Training (Azrin &
Nunn, 1973; Azrin, Nunn & Frantz, 1980) has been hypo-
thetically attributed to its failure to address uncomfortable
inner experiences that trigger TTM. More specifically, some
TTM experts have proposed that habit reversal training is
successful in treating more habitual pulling through aware-
ness enhancement and instruction in the use of alternate mo-
tor routines, but fails to address the pulling related to intense
emotions or sensory experiences (e.g., Flessner et al., 2008;
Keuthen et al., 2010; Woods, Wetterneck & Flessner, 2006).
Woods and colleagues have explored the relationship be-
tween experiential avoidance and TTM and the efficacy of
Acceptance and Commitment Therapy (ACT)-enhanced
habit reversal training for treating this disorder. In an anony-
mous Internet survey, Begotka, Woods and Wetterneck
(2004) demonstrated that individuals with greater experien-
tial avoidance had more severe hair pulling. Subsequent re-
search by this group showed that experiential avoidance can
mediate relationships between hair pulling severity and fear
of negative evaluation, beliefs about appearance, and
shame-related cognitions (Norberg, Wetterneck, Woods &
Conelea, 2007). A multiple baseline study of ACT-en-
hanced habit reversal training revealed significant reduction
in hair pulling severity with self-monitored pulling fre-
quency, self-rated pulling severity and social validity ratings
(Twohig & Woods, 2004). Additionally, reductions in expe-
riential avoidance were significantly associated with reduc-
tions in hair pulling severity at 3-month follow-up. Woods et
al. (2006) subsequently conducted a randomized controlled
trial comparing a 10-week trial of ACT-enhanced habit re-
versal training with a waitlist control for TTM. The treat-
ment group demonstrated significantly greater reductions in
hair pulling severity and impairment, experiential avoid-
ance, anxiety and depression than the waitlist control group.
Symptom improvement was largely maintained at 3-month
follow-up. Decrease in experiential avoidance was signifi-
cantly correlated with reduction in pulling severity.
Our research group has been active in exploring the role
of affective dysregulation in TTM (Shusterman, Feld, Baer
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& Keuthen, 2009) and the potential treatment efficacy of Di-
alectical Behavior Therapy (DBT)-enhanced habit reversal
training (Keuthen et al., 2010, 2011). Our findings from a
large Internet survey of TTM demonstrated that hair pullers
had more difficulty than normal controls in managing their
emotions, with a small to moderate relationship between af-
fective regulation and hair pulling severity (Shusterman
et al., 2009). Additionally, using latent class analysis, we
identified four subtypes consisting of unique emotional pro-
files and demonstrated that cluster membership predicted
hair pulling severity.
In our earlier paper (Keuthen et al., 2010), we summa-
rized the extant literature documenting the potential role of
affective variables in TTM. Recognizing the successful use
of DBT (Linehan, 1993a, 1993b) for other disorders charac-
terized by affective dysregulation and impulsivity, we de-
veloped a novel treatment approach for TTM augmenting
traditional habit reversal training with DBT techniques.
DBT is based upon fundamental behavioral principles, and
incorporates many traditional cognitive and behavioral in-
terventions. However, it also includes skills to address
impulsivity and difficulty tolerating aversive experiences,
with modules on mindfulness, emotion regulation (ER), and
distress tolerance. Although DBT and ACT share some
common conceptual underpinnings, we chose to enhance
traditional habit reversal training with DBT strategies for
several reasons. First, DBT is less conceptually abstract than
ACT and arguably offers more specific skills instruction for
specific treatment targets. Additionally, learning new theo-
retical background is not necessary for the implementation
of DBT by experienced cognitive-behavioral therapists.
Lastly, compelling anecdotal evidence from both clinicians
and individuals with TTM has suggested the incremental
benefit of augmenting traditional treatment approaches for
TTM with DBT skills.
In a pilot open treatment trial of DBT-enhanced habit re-
versal training for TTM, we demonstrated significant im-
provement in hair pulling severity/impairment, ER and anxi-
ety and depressive symptoms at both post-treatment and
3-month maintenance (Keuthen et al., 2010). Expected cor-
relations between ER capacity and hair pulling severity were
demonstrated during both acute and maintenance treatment.
At 3- and 6-month follow-up after the 3-month maintenance
period, significant improvement from baseline still occurred
for all hair pulling severity and ER measures (Keuthen et al.,
2011). At both follow-up time points, significant correla-
tions were reported between changes in hair pulling severity
and ER capacity.
To more rigorously evaluate the efficacy of DBT-en-
hanced treatment (herein referred to as “DBT-enhanced
cognitive-behavioral treatment”) for TTM, we conducted a
randomized controlled trial comparing our augmented treat-
ment with a minimal attention control (MAC) comparison
condition. After acute treatment, participants had 4 mainte-
nance sessions over the following 3 months. Follow-up as-
sessments occurred 3 and 6 months after maintenance treat-
ment with no therapist contact during this time. Participants
initially randomized to the control condition subsequently
received active treatment.
In this study we had several specific hypotheses and also
conducted additional exploratory analyses. First, we ex-
pected significant pre- to post-treatment improvement for
participants in active treatment on all hair pulling and ER
variables, as well as mood and anxiety. Secondly, we pre-
dicted maintenance of treatment benefit with no significant
differences for any time point comparisons between post-
treatment and 6-month follow-up. Thirdly, for the random-
ized controlled trial, we anticipated significantly greater im-
provement after acute treatment on all hair pulling and ER
variables, as well as mood and anxiety, for the DBT-en-
hanced cognitive-behavioral treatment vs. MAC partici-
pants. Lastly, we anticipated an inverse correlation between
changes in hair pulling severity and ER capacity such that
reductions in hair pulling severity would be correlated with
improvement in ER capacity from pre-treatment to post-
treatment, and maintained from post-treatment to all subse-
quent time points after post-treatment.
In addition to these planned aims, we examined changes
in experiential avoidance as a mechanism for change in hair
pulling severity throughout treatment and follow-up given
earlier findings from other researchers. Lastly, we investi-
gated self-report of consumer satisfaction.
METHODS
Participants
Thirty-eight participants (31 female, 7 males) with DSM-IV
TTM were enrolled in the study across two sites (MGH/Har-
vard, Emory). Participants were randomly assigned to the
DBT-enhanced cognitive-behavioral treatment (n = 20) and
MAC (n = 18) study conditions.
Potential participants were preliminarily phone screened
to assess for satisfaction of study criteria. Inclusion criteria
consisted of a primary DSM-IV TTM diagnosis;³ 18 years
of age; a minimum MGH-HPS total scale score of 10; and a
minimum TTM symptom duration of 1 year with no signifi-
cant remissions (as defined by complete abstinence of hair
pulling for a 2-week period during the prior 6 months). All
participants were able to provide informed consent and had
sufficient intellectual capacity to accurately complete
self-report measures. Exclusion criteria entailed the pres-
ence of a serious psychiatric condition including mental re-
tardation, psychosis, pervasive developmental disorder, or-
ganic mental disorders, manic episode, ADHD, suicidality;
alcohol or substance abuse within the past 3 months; the
presence of a serious medical condition that would limit
ability to routinely attend sessions and complete homework
assignments; involvement in other psychotherapy for TTM;
prior cognitive-behavioral treatment for TTM; prior DBT;
and changes in psychotropic medications within 2 months of
baseline assessment. Individuals on stable psychotropic
medications were enrolled as long as they had no plans to
change medication during the study.
Eligible participants were scheduled for an in-person in-
terview with an independent assessor (IA). All IAs had a
minimum of a masters-level degree and received training in
structured assessment interviews by the PI (NJK or BOR) at
their respective site. The baseline evaluation included ad-
ministration of several semi-structured interviews for diag-
nosis, TTM history, and TTM symptom profile, as well as
completion of patient self-report scales. Eligible participants
were enrolled upon completion of the IA interview. The PI
at the alternate site reviewed taped assessments to establish
rating reliability.
The study was registered with ClinicalTrials.gov
(NCT00740909) and IRB approval was obtained at each
study site prior to study initiation. Informed consent was ob-
tained from all subjects after study procedures were ex-
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plained and prior to study participation. This research also
complied with the Code of Ethics of the World Medical As-
sociation (Declaration of Helsinki).
Assessment measures
Our assessment battery included clinician-administered
semi-structured interviews for psychiatric diagnosis, TTM
history, TTM symptom severity and impairment, and global
improvement. Self-report scales were also utilized to assess
TTM severity, mood and anxiety symptoms, ER capacity,
and experiential avoidance. Completion of all baseline study
assessment measures required 1 ½ to 2 hours for most parti-
cipants. Participants were also asked to complete ratings of
consumer satisfaction upon study completion.
Our study battery included the following:
Clinician-administered instruments
A) Psychiatric diagnosis
Structured Clinical Interview for DSM-IV Axis I Disor-
ders–Patient Edition (SCID-P): The SCID-P (First, Spitzer,
Gibbon & Williams, 1995) is a structured interview with ac-
ceptable psychometric properties that is the standard for
psychiatric diagnosis. It was used to assess comorbid psy-
chiatric diagnoses and exclusionary disorders.
Trichotillomania Diagnostic Interview–Revised (TDI-R):
The TDI (Rothbaum & Ninan, 1994) is a semi-structured in-
terview modeled after the SCID consisting of 3-point ratings
of items assessing the DSM-III-R TTM diagnostic criteria.
The TDI was revised to ensure conformity with DSM-IV cri-
teria. (To wit, we changed Item #4 to state “Do you experi-
ence an increasing sense of tension before pulling out the hair,
or when attempting to resist the behavior?” We also added the
question “Does your hair pulling cause you significant dis-
tress or impairment in social, occupational, or other important
areas of functioning?”) The TDI-R was used to establish the
diagnosis of TTM for all study participants.
ADHD Module of the Schedule for Affective Disorders
and Schizophrenia for School-Age Children–Epidemiologic
Version (KSADS-E): The ADHD module of the KSADS-E
(Orvaschel, 1985) is a structured interview used to diagnose
ADHD. All scale items were worded in both the present and
past tense for our study. Adult ADHD was diagnosed if: 1)
full DSM-IV criteria were met by the age of 7 years old, 2) a
chronic symptom course occurred from childhood to adult-
hood, and 3) a moderate or severe level of impairment from
ADHD symptoms was currently endorsed (i.e., ADHD CGI
³ 4).
B) TTM history
Psychiatric Institute Trichotillomania Scale (PITS): The
PITS (Winchel et al., 1992) is a semi-structured guided inter-
view that assesses disorder onset, course, and pulling sites.
Interrater agreement is generally acceptable for scale items
and concurrent validity has been demonstrated between item
scores and self-reported indices of TTM severity.
C) TTM severity and impairment
NIMH Trichotillomania Severity Scale (NIMH-TSS): The
NIMH-TSS (Swedo et al., 1989) is a clinician-rated scale as-
sessing pulling frequency (both on the previous day and dur-
ing the past week), urge intensity, urge resistance, subjective
distress, and interference with daily activities. Items are
rated from 0 (none) to 5 (most severe). This scale has re-
ported sensitivity to changes in symptom severity, adequate
to excellent interrater reliability, and good concurrent valid-
ity with self-reported measures of TTM severity.
NIMH Trichotillomania Impairment Scale (NIMH-TIS):
The NIMH-TIS (Swedo et al., 1989) is a clinician-rated
scale with possible scores ranging from 0 (absent) to 10 (se-
vere). Ratings are based on severity of alopecia, time spent
pulling or hiding damage, ability to control pulling, interfer-
ence, and incapacitation. Psychometric data are limited,
though inter-rater reliability scores have ranged from ade-
quate to excellent, good concurrent validity has been re-
ported, and scale scores are sensitive to changes in symptom
severity with treatment.
D) Global improvement
Clinical Global Improvement Scale (CGI): The CGI (Guy,
1976) is a 7-point Likert scale frequently utilized to measure
improvement in clinical trials. Scores range from 1 (very
much improved) to 7 (very much worse). CGI ratings by the
IAs were used to determine treatment responder status.
Self-report instruments
A) TTM severity
Massachusetts General Hospital Hairpulling Scale
(MGH-HPS): The MGH-HPS (Keuthen et al., 1995) is a
self-report instrument for the assessment of TTM severity. It
consists of seven items including frequency and intensity of
urges, ability to control urges, frequency of hair pulling, re-
sistance to and control over hair pulling, and associated dis-
tress. Items are rated on a severity scale ranging from 0 to 4.
It is a homogeneous scale with good internal consistency.
Scale evaluation with an independent sample documents its
test–retest reliability, convergent and divergent validity, and
sensitivity to change in symptoms.
B) ER capacity
Difficulty in Emotion Regulation Scale (DERS): The DERS
(Gratz & Roemer, 2004) is a 36-item self-report instrument
based on a multidimensional conceptualization of ER. It has
six subscales measuring awareness, clarity, and non-accep-
tance of emotional responses, limited strategies for emotion
regulation with perceived efficacy, and difficulties with im-
pulse control and goal-directed behavior when experiencing
negative emotions. Preliminary data indicate high internal
consistency, good test–retest reliability and adequate con-
struct and predictive validity. Lower scores reflect greater
emotion regulation capacity.
Generalized Expectancy for Negative Mood Regulation
Scale (NMR): The NMR (Catanzaro & Mearns, 1990) is a
30-item self-report scale used to assess expectations that spe-
cific behaviors or cognitions will alleviate a negative mood
state. Items are rated on a 5-point scale ranging from 1 (strong
disagreement) to 5 (strong agreement). High internal consis-
tency coefficients, discriminant validity from social desirabil-
ity, and temporal stability have been reported. Higher scores
reflect greater expected capacity to regulate emotions.
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Affective Regulation Rating (ARR): The ARR is a
5-point Likert scale designed for this study to measure per-
ceived ability to modulate TTM-related mood states. We de-
veloped this instrument out of concern that existing ER mea-
sures may be insufficient to target the unique emotion regu-
lation difficulties individual hair pullers may experience. In-
dividuals are instructed to review a list of twelve moods (in-
cluding bored, angry, guilty, indifferent, happy, calm, tense,
irritable, sad, anxious, relieved, and ashamed) and identify
the 3 moods most likely to have triggered their TTM during
the prior week. They then rate their ability to modulate those
moods from 1 (not at all able) to 5 (completely able).
C) Mood and anxiety
Beck Depression Inventory-II (BDI-II): The BDI-II (Beck,
Steer & Brown, 1996) is a 21-item self-report inventory that
assesses the severity of depression. It is an updated version
of the original BDI with item content matched to DSM-IV
criteria for a major depressive episode. The BDI-II has high
internal consistency and evidence for construct validity in-
cludes elevated BDI-II scores in psychiatric outpatient sam-
ples.
Beck Anxiety Inventory (BAI): The BAI (Beck, Epstein,
Brown & Steer, 1988) is a 21-item self-report inventory de-
signed to assess anxiety severity. The BAI is reported to
have high internal consistency and its one-week test–retest
reliability is satisfactory.
D) Experiential avoidance
Acceptance and Action Questionnaire (AAQ): The AAQ
(Hayes et al., 2004) is a 9-item instrument used to measure
experiential avoidance. It has documented internal consis-
tency, as well as good convergent, divergent and discrimi-
nant validity. Lowered scores on this measure indicate less
avoidance of uncomfortable private events.
E) Consumer satisfaction
Consumer Satisfaction Form (CSF): The CSF is a 4-item
self-report scale developed for this study to assess treatment
satisfaction, condition status, change in condition and extent
to which change is perceived to be treatment-related. For the
first three items, response scores ranged from 1 (very satis-
fied/excellent/much better) to 7 (very dissatisfied/extremely
poor/much worse). Ratings for perceived condition change
related to treatment ranged from 1 (definitely related) to 5
(definitely not related).
Procedures
Participants randomized to the treatment arm of the study re-
ceived 11 weekly 50-minute acute treatment sessions. Study
therapists delivered a manualized treatment protocol devel-
oped by study authors (NJK, BOR, SSW) that was previ-
ously studied in our open treatment pilot study. The treat-
ment encompassed standard habit reversal training and stim-
ulus control techniques augmented with DBT strategies
deemed to be relevant to TTM. The DBT techniques adopted
for this treatment were tailored to specifically address TTM.
The session content format for the acute treatment protocol
included: Session 1: Psychoeducation, motivational inter-
viewing, chain analysis and self-monitoring; Session 2:
Competing response, stimulus control procedures and pre-
vention training; Sessions 3–5: Mindfulness training; Ses-
sions 6–8: Emotion regulation training; Sessions 9–10: Dis-
tress tolerance training; and Session 11: Relapse prevention
training. Subsequent maintenance treatment (Sessions
12–15) had an emphasis on relapse prevention and review of
prior techniques. (For further description of the treatment
protocol, please refer to Keuthen et al. [2010].)
The first treatment session was scheduled within 1 week
of the baseline assessment. After the acute treatment was
completed, participants had 4 booster sessions over the fol-
lowing 3 months (at 2, 4, 8 and 12 weeks post-treatment).
Study therapists were trained in protocol delivery by their
site PI.
All study sessions were videotaped for supervision as
well as treatment integrity ratings by the alternate site PI.
Ten percent of all study tapes (both MAC and treatment ses-
sions) were rated for adherence and competence. Treatment
integrity coding was based on an adaptation of the Nishith
and Resick (1994) rating system. Ratings were made for
protocol adherence (presence/absence) and competence (1
[very poor] to 7 [excellent]). Tapes were rated as 99% adher-
ent for the treatment sessions and 100% adherent for the
MAC sessions. Mean therapist skill ratings for the acute
treatment sessions were 6.59 (SD = 0.43) for the unique and
essential elements of the protocol and 6.76 (SD = 0.27) for
the essential but not unique elements of the protocol. Mean
therapist ratings for the MAC sessions were 6.83 (SD = 0.35)
for the unique and essential elements of the protocol and
6.71 (SD = 0.52) for the essential but not unique elements of
the protocol.
The MAC condition was designed to control for time,
therapist contact and repeat assessments. We did not choose
another credible treatment (e.g., medication, habit reversal
treatment alone or ACT-enhanced habit reversal training)
for the comparison condition as we first wanted to investi-
gate if: 1) our augmented treatment resulted in maintenance
of gains at follow-up (which has generally not been the case
for habit reversal treatment alone) and 2) whether changes in
hair pulling severity were correlated with changes in emo-
tion regulation capacity during and after treatment. Partici-
pants assigned to this study arm received a weekly phone
call from the study therapist to assess general functioning,
safety, occurrence of stressors and medication use. Thera-
pists did not inquire about hair pulling status or provide ad-
vice if asked by the participant. Upon completion of the
MAC condition, all participants then received the active
treatment protocol.
Follow-up IA assessments occurred at 3 and 6 months
after completion of maintenance treatment. Similar evalua-
tions were conducted at these time points to those performed
at baseline, post-treatment and 3-month maintenance.
RESULTS
Study sample
See Table 1 for the demographic and clinical profiles of
study participants. Our sample consisted largely of young
female adults with college degrees or graduate school edu-
cation. Illness onset was generally in early adolescence with
a lengthy duration of illness. Baseline TTM severity was in
the moderate range with mild to moderate severity of associ-
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ated functional impairment. Mood and anxiety symptoms
were non-clinical in severity.
Participants randomized to the DBT-enhanced cogni-
tive-behavioral treatment condition (n = 20) did not signifi-
cantly differ (p > .05) from those in the MAC condition
(n = 18) with the exception of gender (X2 = 5.06, p = .02).
The treatment arm had 19 females and 1 male while the
MAC condition had 12 females and 6 males. Current
comorbidity for the DBT-enhanced cognitive-behavioral
treatment group included GAD (n = 1) and anxiety NOS
(n = 1). Current comorbidity for the MAC group included
social phobia (n = 1) and anxiety NOS (n = 1). Lifetime
comorbidity for the DBT enhanced cognitive-behavioral
treatment group included MDD (n = 6), substance-induced
mood disorder (n = 1), anxiety NOS (n = 1), bulimia (n = 1)
and Tourette’s disorder (n = 1). Lifetime comorbidity for the
MAC group included MDD (n = 7), depression NOS (n = 1),
alcohol abuse (n = 1), alcohol dependence (n = 1), cannabis
abuse (n = 1), panic disorder (n = 1), social phobia (n = 1),
specific phobia (n = 1), anxiety NOS (n = 1) and bulimia
(n = 1). Current psychotropic medications reported for the
DBT-enhanced cognitive-behavioral treatment group were
n-acetyl cysteine (n = 1) and zolpidem (n = 1) and for the
MAC group were sertraline (n = 1), venlafaxine (n = 1),
zolpidem (n = 1) and alprazolam (n = 1). No medication
changes were reported during acute treatment. One partici-
pant reported a 10-day hiatus in her sertraline only during
the last month of the maintenance treatment.
During the randomized controlled trial, there were two
dropouts (both initially randomized to active treatment).
Upon completion of the randomized controlled trial, all
MAC participants received the treatment protocol; three of
these participants dropped out before completing acute treat-
ment. Additional participants subsequently dropped out dur-
ing 3-month maintenance (n = 1), 3-month follow-up (n = 1)
and 6-month follow-up (n = 1). Comparison of completers
through 3-month maintenance treatment (n = 32) with drop-
outs (n = 6) did not reveal significant group differences
(p >. 05) on demographics (age, illness onset, illness dura-
tion, gender, education), hair pulling severity or impairment,
mood and anxiety or experiential avoidance. For ER
capacity, completers did not differ from dropouts on DERS
total or NMR total scores; on the ARR, dropouts had sig-
nificantly higher baseline ER scores than completers indi-
cating a greater ability to control mood states that trigger
hair pulling.
Efficacy of DBT-enhanced cognitive-behavioral treatment
for TTM
Tests of normality and visual inspection of residual plots
provided evidence for non-normal distributions for several
study variables. Accordingly, we chose non-parametric
analyses to investigate treatment outcome.
See Table 2. Pre- to post-treatment Wilcoxon signed
ranks paired samples tests for all participants during DBT-
enhanced cognitive-behavioral treatment revealed signifi-
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Table 1. Baseline descriptive statistics for demographic and clinical
variables for all study participants (n = 38)
Demographics
Age (yrs) 30.71 (8.55)
Female, n (%) 31 (81.60)
Education, n (%)
HS grad/GED 6 (15.8)
Associates or technical degree 2 (5.3)
College graduate 17 (44.7)
Graduate school 12 (31.6)
Illness onset (age) 13.58 (5.70)
Duration of illness (yrs) 17.13 (8.49)
Hair pulling severity
MGH-HPS 17.42 (3.41)
NIMH-TSS 16.16 (3.67)
Hair pulling impairment
NIMH-TIS 6.79 (1.04)
Emotion regulation
ARR 7.79 (1.56)
DERS total 77.39 (19.83)
NMR total 106.55 (11.45)
Experiential avoidance
AAQ 34.34 (7.70)
Mood and anxiety
BDI-II 9.38 (6.41)
BAI 5.51 (4.86)
Table 2. Means and standard deviations for all variables at each study time point during the open treatment trial
Pre-treatment Post-treatment 3-month maintenance 3-month follow-up 6-month follow-up
(n = 38) (n = 33) (n = 32) (n = 30)** (n = 30)
Hair pulling
MGH-HPS 16.71 ± 4.04a,b,c,d 7.30 ± 4.03f,g 7.09 ± 4.64h,i 8.93 ± 3.44 8.83 ± 4.51
NIMH-TSS 15.71 ± 3.49a,b,c,d 6.06 ± 4.64 5.59 ± 5.36 6.33 ± 4.65 6.93 ± 4.70
NIMH-TIS 7.11 ± 1.52a,b,c,d 4.67 ± 2.17e 3.41 ± 2.61 3.67 ± 2.45 3.63 ± 2.63
Emotion regulation
ARR* 7.82 ± 1.69a,b,c,d 11.12 ± 2.30 11.59 ± 2.03 11.03 ± 2.17 10.76 ± 2.40
DERS total 74.68 ± 18.52 71.15 ± 19.13 68.28 ± 17.40 67.90 ± 17.69 68.45 ± 16.58
NMR total* 107.08 ± 12.18a,b,d 111.42 ± 13.99 113.03 ± 12.81 110.38 ± 15.97 111.93 ± 14.20
Experiential avoidance
AAQ 32.84 ± 6.97a,b,c,d 30.79 ± 7.20 29.81 ± 7.39 29.59 ± 7.73 29.17 ± 7.72
Depression and anxiety
BDI 7.00 ± 5.88a,b,c,d 4.58 ± 6.06 3.47 ± 4.91 4.44 ± 5.75 3.52 ± 4.47
BAI 5.14 ± 4.83a,b,c,d 3.55 ± 7.47 2.26 ± 2.61 2.75 ± 4.77 2.89 ± 3.84
* Higher scores reflect better functioning.
** Missing data for 1 participant at 3-month follow-up.
a p £ .05 (pre-tx, post-tx), b p £ .05 (pre-tx, 3-mo maintenance), c p £ .05 (pre-tx, 3-mo f-u), d p £ .05 (pre-tx, 6-mo f-u), e p £ .05 (post-tx, 3-mo
maintenance), f p£ .05 (post-tx, 3-mo f-u), g p£ .05 (post-tx, 6-mo f-u), h p£ .05 (3-mo maintenance, 3-mo f-u), i p£ .05 (3-mo maintenance, 6-mo
f-u).
cant improvement in both TTM severity (MGH-HPS total:
Z = 5.02, p < .001; NIMH-TSS: Z = 5.02, p < .001) and im-
pairment (NIMH-TIS: Z = 4.40, p < .001). Pre- to post-treat-
ment improvement in ER capacity was reported (ARR: Z =
4.43, p < .001; NMR total: Z = 3.44, p = .001). Subsequent
analysis of NMR subscale scores revealed significant pre- to
post-treatment improvement on the NMR general (Z = 2.92,
p < .01), cognitive (Z = 2.08, p = .04), and behavioral (Z =
3.69, p < .001) subscale scores. No significant changes in
DERS scores occurred from pre- to post-treatment. Signifi-
cant improvement was also reported in experiential avoid-
ance (AAQ: Z = 2.38, p = .02), depression (BDI: Z = 2.83, p
< .01) and anxiety (BAI: Z = 3.56, p < .001).
Maintenance of improvement with DBT-enhanced
cognitive-behavioral treatment for TTM
No significant changes in ER capacity, experiential avoid-
ance, depression or anxiety occurred for any time point com-
parison between post-treatment and 6-month follow-up.
Significant improvement for these variables was still re-
ported from pre-treatment to 3-month maintenance,
3-month follow-up and 6-month follow-up (with the excep-
tion of the non-significant change in NMR total scores from
pre-treatment to 3-month follow-up).
There were, however, some significant changes in hair
pulling severity and impairment from post-treatment to later
time points. MGH-HPS scores worsened slightly from
post-treatment to 3- and 6-month follow-up and from
3-month maintenance to 3- and 6-month follow-up. Con-
versely, significant improvement in TTM impairment was
reported for the TIS from post-treatment to 3-month mainte-
nance. Despite the changes noted above, significant im-
provement on all TTM variables was still reported for time
point comparisons between pre-treatment and 3-month
maintenance, 3-month follow-up and 6-month follow-up.
Comparison of DBT-enhanced cognitive-behavioral
treatment to MAC during acute treatment of TTM
See Table 3. Mann–Whitney U independent samples t-tests
comparing DBT-enhanced cognitive-behavioral treatment
and MAC completers on baseline to week 11 change scores
revealed group differences in hair pulling severity
(MGH-HPS: U = 23.50, p < .001; NIMH-TSS: U = 28.00, p
< .001) and impairment (NIMH-TIS: U = 50.00, p < .001).
The two groups were also significantly different on change
in ER capacity on the ARR (U = 42.50, p < .001) but not on
the DERS or NMR total scores. Greater improvement on
hair pulling and ER measures was consistently reported for
the DBT-enhanced cognitive-behavioral treatment vs. MAC
study conditions. The two groups were not significantly dif-
ferent pre- to post-treatment in experiential avoidance, de-
pression or anxiety scores.
Baseline to week 11 Wilcoxon signed ranks paired sam-
ples t-tests for DBT-enhanced cognitive-behavioral treat-
ment participants only in the randomized controlled trial re-
vealed significant improvement for hair pulling severity/ im-
pairment (MGH-HPS total, NIMH-TSS, NIMH-TIS), ER
capacity (ARR, NMR total), depression (BDI) and anxiety
(BAI). Subsequent analysis revealed significant improve-
ment on all NMR subscales. For participants in the MAC
condition, baseline to week 11 paired samples t-tests failed
to yield significant improvements on all hair pulling and ER
measures; however, analyses did reveal significant improve-
ments on the AAQ and BDI indicating lowered experiential
avoidance and fewer depressive symptoms at week 11.
Total abstinence from hair pulling was reported for 5
DBT-enhanced cognitive-behavioral treatment participants
and 1 MAC participant at week 11. [Total abstinence was
defined by a score of “0” on both MGH-HPS items #4 (fre-
quency of hair pulling) and #6 (control over hair pulling].
Full responders (CGI £ 2 and ³ 35% decrease in
MGH-HPS total scores) at week 11 included 11 DBT-en-
hanced cognitive-behavioral treatment participants and 1
MAC participant.
Relationship between ER capacity
and AAQ with hair pulling measures at baseline
Evidence for non-normal bivariate distributions led us to use
non-parametric statistics to examine baseline relationships
between hair pulling measures and both ER capacity and ex-
periential avoidance. No significant Spearman’s rho correla-
tions (p > .05) were reported at baseline between ER mea-
sures or experiential avoidance and hair pulling measures.
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Table 3. Means and standard deviations at baseline and 11 weeks for completers in the DBT-enhanced cognitive-behavioral treatment
(CBT) and MAC study conditions
DBT-enhanced CBT (n = 18) MAC (n = 18)
Baseline 11 weeks Baseline 11 weeks
Hair pulling
MGH-HPS total* 18.10 ± 2.97 7.72 ± 3.75 16.67 ± 3.79 15.17 ± 4.57
NIMH-TSS* 17.15 ± 3.41 7.00 ± 4.92 15.06 ± 3.73 14.11 ± 2.89
NIMH-TIS* 6.85 ± 0.93 5.22 ± 1.86 6.72 ± 1.18 6.67 ± 1.19
Emotion regulation
ARR* 7.65 ± 1.81 11.67 ± 2.22 7.94 ± 1.26 8.00 ± 1.57
DERS total 73.75 ± 21.95 72.28 ± 21.88 81.44 ± 16.86 75.72 ± 14.35
NMR total 109.40 ± 13.18 114.11 ± 16.05 103.39 ± 8.43 104.50 ± 10.75
Experiential avoidance
AAQ 33.45 ± 7.69 31.28 ± 8.24 35.33 ± 7.81 32.17 ± 6.20
Depression and anxiety
BDI 8.15 ± 5.31 4.83 ± 6.45 10.82 ± 7.40 5.72 ± 6.35
BAI 5.50 ± 5.37 2.28 ± 3.12 5.53 ± 4.35 4.67 ± 4.15
*p < .05 for independent samples t-tests comparing group differences from baseline to 11 weeks.
112 | Journal of Behavioral Addictions 1(3), pp. 106–114 (2012)
Keuthen et al.
Relationship between changes in ER capacity and AAQ
with changes in TTM measures with treatment
No significant correlations were reported for the entire sam-
ple from pre- to post-treatment between changes in ER and
TTM measures. From pre-treatment to 3-month mainte-
nance, changes in DERS total scores were significantly cor-
related with changes in both MGH-HPS total scores (rS =
.45, p = .01) and NIMH-TIS scores (rS = .44, p = .01). Subse-
quent analyses revealed significant correlations between
changes in DERS non-acceptance subscale scores and
changes in MGH-HPS total (rS = .35, p = .05) and
NIMH-TSS (rS = .37, p = .04) scores. Changes in DERS
awareness subscale scores were correlated with changes in
NIMH-TIS scores (rS = .50, p < .01). Changes in DERS clar-
ity subscale scores and NIMH-TIS scores were significantly
correlated (rS = .44, p = .01). Marginal correlations (.05 < p <
.10) were reported for changes in DERS total and
NIMH-TSS scores, changes in ARR and MGH-HPS total
scores, and changes in DERS goals and MGH-HPS total
scores. In all instances, improved ER capacity was corre-
lated with reduced TTM severity or impairment.
From pre-treatment to 3-month follow-up, changes in
ARR scores were significantly correlated with changes in
MGH-HPS total scores (rS = –.40, p = .03) and NIMH-TSS
scores (rS = –.40, p = .03). The correlation between ARR
scores and NIMH-TIS scores was marginally significant. In
all instances, improved ER capacity was correlated with re-
duced TTM severity or impairment.
From pre-treatment to 6-month follow-up, changes in
ARR scores were significantly correlated with changes in
MGH-HPS total scores (rS = –.61, p < .001), NIMH-TSS
scores (rS = –.46, p = .01), and NIMH-TIS scores (rS = –.47,
p < .01). Changes in NMR total scores were also signifi-
cantly correlated with changes in MGH-HPS (rS = –.42, p =
.02) and NIMH-TIS (rS = –.39, r = .04) scores. Subsequent
analyses of correlations between NMR subscale and TTM
scores indicated significant correlations between changes in
NMR cognitive subscale and NIMH-TIS scores (rS = –.45,
p =.02). Marginally significant correlations were reported
between changes in both NMR general and cognitive
subscale scores and changes in MGH-HPS total scores. In all
instances, improved ER capacity was correlated with re-
duced TTM severity or impairment.
Changes in AAQ scores were correlated with changes in
NIMH-TSS (rS = .40, p = .03) and NIMH-TIS (rS = .52,
p < .01) scores only at 6-month follow-up. Reduced experi-
ential avoidance was correlated with reduced TTM severity
and impact.
Consumer satisfaction with DBT-enhanced
cognitive-behavioral treatment
On the CSF, treatment satisfaction ratings ranged from
“moderately satisfied” to “very satisfied” (post-treatment:
M = 1.24, SD = 0.50; 3-month maintenance: M = 1.20, SD =
0.41; 3-month follow-up: M = 1.75, SD = 0.75; 6-month fol-
low-up: M = 1.62, SD = 0.77). Ratings of current condition
ranged from “good” to “excellent” (post-treatment: M = 2.15,
SD = 1.00; 3-month maintenance: M = 1.96, SD = 0.89;
3-month follow-up: M = 2.67, SD = 0.98; 6-month fol-
low-up: M = 2.92, SD = 1.19). Ratings of condition change
largely ranged from “somewhat better” to “much better”
(post-treatment: M = 1.42, SD = 0.56; 3-month maintenance:
M = 1.36, SD = 0.64; 3-month follow-up: M = 2.00, SD =
0.85; 6-month follow-up: M = 2.08, SD = 0.76). Ratings of
treatment-related condition status ranged from “probably re-
lated” to “definitely related” (post-treatment: M = 1.12,
SD = 0.33; 3-month maintenance: M = 1.40, SD = 0.96;
3-month follow-up: M = 1.50, SD = 0.90; 6-month fol-
low-up: M = 1.69, SD = 0.95).
DISCUSSION
Our open treatment trial results demonstrated significant im-
provement in TTM severity and impairment, emotion regu-
lation capacity, experiential avoidance, and mood and anxi-
ety with our DBT-enhanced cognitive-behavioral treatment
protocol. These improvements largely maintained through-
out 6-month follow-up. Although there was some loss of
gains following treatment on our self-report instrument of
TTM severity, participants remained significantly improved
from pre-treatment to all time points after post-treatment.
Our randomized controlled trial results demonstrated
greater improvement in TTM severity and impairment for
participants in our active treatment vs. MAC conditions. Our
treatment group notably demonstrated greater improvement
in ER capacity over the MAC group on only one ER measure
(the ARR). This finding is consistent with Shusterman
et al.’s (2009) argument that more idiographic assessment of
ER difficulties is warranted for hair pullers. Existing mea-
sures (e.g., the DERS and NMR) globally assess affect regu-
lation with an emphasis on depression and anxiety, failing to
assess the full range of emotional triggers potentially related
to TTM (e.g, omits boredom). For this reason, we designed
the ARR to evaluate emotion regulation in TTM. We in-
cluded both the DERS and NMR given that it was unclear
from our earlier pilot findings whether they measured the
same ER construct. Not unexpectedly, we found different
correlations for these two measures with other variables
throughout the study. Future research should more fully ex-
amine the structure and relationship of these ER measures as
well as develop assessment tools that better capture ER in
this disorder. In a similar vein, it is also important to explore
whether the AAQ is the best measure of experiential avoid-
ance in TTM, as well as examine the relationships between
experiential avoidance and ER in this disorder.
The MAC and active treatment conditions did not differ
from baseline to week 11 on mood, anxiety or experiential
avoidance. For the treatment group alone, significant im-
provement in ER capacity (on both the ARR and NMR),
plus depression and anxiety, was demonstrated from base-
line to week 11. Unexpectedly, though, significant improve-
ment was also demonstrated for the MAC group for both ex-
periential avoidance and depression from baseline to week
11, suggesting that MAC was not an inert control condition.
It is possible that a weekly, albeit brief, open-ended phone
inquiry (“How was your week?”) may positively impact
mood and lower experiential avoidance through the mecha-
nisms of social support and/or awareness enhancement.
It is of interest that no significant correlations between
ER capacity (or experiential avoidance) and TTM measures
were reported at baseline. Limited affective comorbidity in
our sample may have hampered our ability to document this
relationship. One might also postulate that lack of emotional
awareness at baseline may limit one’s ability to accurately
assess ER capacity. The increased number of correlations re-
ported between ER capacity and TTM at later study time
points may reflect the maturation of affect regulation skills,
including emotional awareness, with increased study partic-
ipation. Future psychopathology research in TTM should
examine awareness of affective experiences and the trajec-
tory of affective triggers over time.
It is important to recognize limitations to our study. Our
enrollment criteria yielded a study sample with reduced
comorbid psychiatric illness, few participants on psycho-
tropic medications, and no hair pullers with prior DBT or
cognitive-behavioral treatment for TTM. It is always a chal-
lenge in designing initial investigations of novel treatments
to balance internal and external validity. As an initial step to
investigate our protocol, we decided to control for those
variables that we anticipated might mitigate our ability to
demonstrate efficacy with our treatment. Alternatively, one
could argue that more robust findings related to change in
ER capacity with treatment, and correlations between
change in ER capacity and TTM severity, might have oc-
curred if there had been a greater range in affective symptom
severity in study participants. Future studies should examine
our treatment protocol in TTM samples with greater affec-
tive comorbidity.
Similarly, our choice of MAC as the control condition
does not shed light on how our DBT-enhanced cognitive-be-
havioral protocol would fare when compared to other treat-
ments with some empirical evidence of efficacy. Thus, fu-
ture studies should compare our treatment intervention to
other active treatment comparison conditions (e.g., habit re-
versal training alone, ACT-enhanced habit reversal training
and psychopharmacological treatments) in larger-scale in-
vestigations. Additionally, our study design does not allow
us to identify the treatment element(s) responsible for symp-
tom improvement nor can we draw conclusions regarding
the number of treatment sessions necessary for change. Fu-
ture dismantling studies and investigations comparing inter-
ventions of varying duration will help to address these im-
portant issues. Lastly, researchers should also investigate the
ability to disseminate our treatment to community treatment
providers and its effectiveness in community samples.
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